PrP assemblies: Spotting the responsible regions in prion propagation

Prion

Volumn 5, Issue 2, 2011, Pages 69-75

  Prigent, Stéphanie ^a   Rezaei, Human ^a  

^a INRA Institut National de la Recherche Agronomique   (France)

Author keywords

Amyloid; Domain of replication; Fibers; H2H3; Polymer; Prion; Strain; Unfolding

Indexed keywords

PRION PROTEIN;

CARBOXY TERMINAL SEQUENCE; CYTOTOXICITY; NOTE; OLIGOMERIZATION; PATHOGENESIS; PRION DISEASE; PROTEIN ASSEMBLY; PROTEIN DOMAIN;

ANIMALS; HUMANS; HYDROGEN-ION CONCENTRATION; PRIONS; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY;

EID: 79959381265     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.5.2.16383     Document Type: Note

References (44)

1. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216:136-44. (Pubitemid 12089840)
2. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95:13363-83.
3. Griffith JS. Self-replication and scrapie. Nature 1967; 215:1043-4.
4. Come JH, Fraser PE, Lansbury PT Jr. A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc Natl Acad Sci USA 1993; 90:5959-63. (Pubitemid 23191433)
5. Jackson GS, Hosszu LL, Power A, Hill AF, Kenney J, Saibil H, et al. Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. Science 1999; 283:1935-7.
6. Swietnicki W, Morillas M, Chen SG, Gambetti P, Surewicz WK. Aggregation and fibrillization of the recombinant human prion protein huPrP90-231. Biochemistry 2000; 39:424-31. (Pubitemid 30056478)
7. Rezaei H, Eghiaian F, Perez J, Doublet B, Choiset Y, Haertle T, et al. Sequential generation of two structurally distinct ovine prion protein soluble oligomers displaying different biochemical reactivities. J Mol Biol 2005; 347:665-79. (Pubitemid 40332372)
8. Chiti F, Dobson CM. Amyloid formation by globular proteins under native conditions. Nat Chem Biol 2009; 5:15-22.
9. Shmerling D, Hegyi I, Fischer M, Blattler T, Brandner S, Gotz J, et al. Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 1998; 93:203-14.
10. Calzolai L, Zahn R. Influence of pH on NMR structure and stability of the human prion protein globular domain. J Biol Chem 2003; 278:35592-6. (Pubitemid 37102332)
11. Eghiaian F, Daubenfeld T, Quenet Y, van Audenhaege M, Bouin AP, van der Rest G, et al. Diversity in prion protein oligomerization pathways results from domain expansion as revealed by hydro gen/deuterium exchange and disulfide linkage. Proc Natl Acad Sci USA 2007; 104:7414-9. (Pubitemid 47185920)
12. Kaneko K, Zulianello L, Scott M, Cooper CM, Wallace AC, James TL, et al. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc Natl Acad Sci USA 1997; 94:10069-74.
13. Perez DR, Damberger FF, Wuthrich K. Horse prion protein NMR structure and comparisons with related variants of the mouse prion protein. J Mol Biol 2010; 400:121-8.
14. Sigurdson CJ, Nilsson KP, Hornemann S, Manco G, Fernandez-Borges N, Schwarz P, et al. A molecular switch controls interspecies prion disease transmission in mice. J Clin Invest 2010; 120:2590-9.
15. Rezaei H, Choiset Y, Eghiaian F, Treguer E, Mentre P, Debey P, et al. Amyloidogenic unfolding intermediates differentiate sheep prion protein variants. J Mol Biol 2002; 322:799-814.
16. Baskakov IV, Legname G, Prusiner SB, Cohen FE. Folding of prion protein to its native alpha-helical conformation is under kinetic control. J Biol Chem 2001; 276:19687-90.
17. Hafner-Bratkovic I, Bester R, Pristovsek P, Gaedtke L, Veranic P, Gaspersic J, et al. Globular domain of the prion protein needs to be unlocked by domain swapping to support prion protein conversion. J Biol Chem 2011; 286:12149-56.
18. Koshland DE. Application of a Theory of Enzyme Specificity to Protein Synthesis. Proc Natl Acad Sci USA 1958; 44:98-104.
19. Wille H, Michelitsch MD, Guenebaut V, Supattapone S, Serban A, Cohen FE, et al. Structural studies of the scrapie prion protein by electron crystallography. Proc Natl Acad Sci USA 2002; 99:3563-8. (Pubitemid 34252147)
20. Morrissey MP, Shakhnovich EI. Evidence for the role of PrP(C) helix 1 in the hydrophilic seeding of prion aggregates. Proc Natl Acad Sci USA 1999; 96:11293-8.
21. Sawaya MR, Sambashivan S, Nelson R, Ivanova MI, Sievers SA, Apostol MI, et al. Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature 2007; 447:453-7. (Pubitemid 46816731)
22. Vanik DL, Surewicz KA, Surewicz WK. Molecular basis of barriers for interspecies transmissibility of mammalian prions. Mol Cell 2004; 14:139-45. (Pubitemid 38469916)
23. Tateishi J, Kitamoto T, Hoque MZ, Furukawa H. Experimental transmission of Creutzfeldt-Jakob disease and related diseases to rodents. Neurology 1996; 46:532-7. (Pubitemid 26081345)
24. Khan MQ, Sweeting B, Mulligan VK, Arslan PE, Cashman NR, Pai EF, et al. Prion disease susceptibility is affected by beta-structure folding propensity and local side-chain interactions in PrP. Proc Natl Acad Sci USA 2010; 107:19808-13.
25. Cobb NJ, Sonnichsen FD, McHaourab H, Surewicz WK. Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure. Proc Natl Acad Sci USA 2007; 104:18946-51.
26. Cobb NJ, Surewicz WK. Prion strains under the magnifying glass. Nat Struct Mol Biol 2007; 14:882-4. (Pubitemid 47525167)
27. De Simone A, Zagari A, Derreumaux P. Structural and hydration properties of the partially unfolded states of the prion protein. Biophys J 2007; 93:1284-92. (Pubitemid 47330908)
28. Chakroun N, Prigent S, Dreiss CA, Noinville S, Chapuis C, Fraternali F, et al. The oligomerization properties of prion protein are restricted to the H2H3 domain. FASEB J 2010; 24:3222-31.
29. Adrover M, Pauwels K, Prigent S, de Chiara C, Xu Z, Chapuis C, et al. Prion fibrillization is mediated by a native structural element that comprises helices H2 and H3. J Biol Chem 2010; 285:21004-12.
30. Lu X, Wintrode PL, Surewicz WK. Beta-sheet core of human prion protein amyloid fibrils as determined by hydrogen/deuterium exchange. Proc Natl Acad Sci USA 2007; 104:1510-5. (Pubitemid 46214621)
31. Tycko R, Savtchenko R, Ostapchenko VG, Makarava N, Baskakov IV. The alpha-Helical C-Terminal Domain of Full-Length Recombinant PrP Converts to an In-Register Parallel beta-Sheet Structure in PrP Fibrils: Evidence from Solid State Nuclear Magnetic Resonance. Biochemistry 2010.
32. Kryndushkin DS, Wickner RB, Tycko R. The Core of Ure2p Prion Fibrils Is Formed by the N-Terminal Segment in a Parallel Cross-beta Structure: Evidence from Solid-State NMR. J Mol Biol 2011.
33. Baskakov IV, Legname G, Baldwin MA, Prusiner SB, Cohen FE. Pathway complexity of prion protein assembly into amyloid. J Biol Chem 2002; 277:21140-8. (Pubitemid 34952249)
34. Collinge J, Clarke AR. A general model of prion strains and their pathogenicity. Science 2007; 318:930-6. (Pubitemid 350098981)
35. Gorbenko GP, Kinnunen PK. The role of lipid-protein interactions in amyloid-type protein fibril formation. Chem Phys Lipids 2006; 141:72-82. (Pubitemid 43728804)
36. Morillas M, Swietnicki W, Gambetti P, Surewicz WK. Membrane environment alters the conformational structure of the recombinant human prion protein. J Biol Chem 1999; 274:36859-65.
37. Wang F, Wang X, Yuan CG, Ma J. Generating a prion with bacterially expressed recombinant prion protein. Science 2010; 327:1132-5.
38. Wang F, Yin S, Wang X, Zha L, Sy MS, Ma J. Role of the highly conserved middle region of prion protein (PrP) in PrP-lipid interaction. Biochemistry 2010; 49:8169-76.
39. van der Kamp MW, Daggett V. The consequences of pathogenic mutations to the human prion protein. Protein Eng Des Sel 2009; 22:461-8.
40. Kuwata K, Nishida N, Matsumoto T, Kamatari YO, Hosokawa-Muto J, Kodama K, et al. Hot spots in prion protein for pathogenic conversion. Proc Natl Acad Sci USA 2007; 104:11921-6. (Pubitemid 47185606)
41. Parchi P, Strammiello R, Giese A, Kretzschmar H. Phenotypic variability of sporadic human prion disease and its molecular basis: past, present and future. Acta Neuropathol 2011; 121:91-112.
42. Simoneau S, Rezaei H, Sales N, Kaiser-Schulz G, Lefebvre-Roque M, Vidal C, et al. In vitro and in vivo neurotoxicity of prion protein oligomers. PLoS Pathog 2007; 3:125.
43. Chich JF, Chapuis C, Henry C, Vidic J, Rezaei H, Noinville S. Vesicle permeabilization by purified soluble oligomers of prion protein: a comparative study of the interaction of oligomers and monomers with lipid membranes. J Mol Biol 2010; 397:1017-30.
44. Noinville S, Chich JF, Rezaei H. Misfolding of the prion protein: linking biophysical and biological approaches. Vet Res 2008; 39:48.